The COVID-19 Vaccine Moderna was authorized on December 23, 2020, for use in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 . Since the time of authorization, new information pertaining to post-market adverse reactions has been identified following COVID-19 Vaccine Moderna administration outside of clinical trials. In addition, the PM and global English-only vial and carton labels have been updated with new product labelling information.
RecallTracker